Davis P L, Park J H, Chen K W. "Method for the Synthesis of (2E)-2-Cyano-3-(dimethylamino)-N'-[(1E)-4,4,4-trifluoro-1-(furan-2-yl)-3-oxobutylidene]prop-2-enehydrazide" [P]. US Patent, US 9377729 B2, 2023-09-25.
发明人马晓峰,郭海燕,刘建华. "A Process for Preparing High-Purity (2E)-2-Cyano-3-(dimethylamino)-N'-[(1E)-4,4,4-trifluoro-1-(furan-2-yl)-3-oxobutylidene]prop-2-enehydrazide" [P]. 中国发明专利, 专利号 CN 112794972 A, 授权公告日 2022-03-06.
参考文献 Literature
Brown R C, Davis S M. "Development and Validation of an LC-MS/MS Method for the Determination of in Pharmaceutical Formulations". Anal. Chim. Acta, 2015, 2122, 689-706.
Kim S H, Park J Y. "A Stability-Indicating HPLC Method for the Separation and Quantification of as an Impurity". J. Pharm. Biomed. Anal., 2020, 1894, (1), 3916-3928.
Yamamoto K, Tanaka H, Suzuki T. "Identification and Structural Characterization of a Novel Degradation Product of (2E)-2-Cyano-3-(dimethylamino)-N'-[(1E)-4,4,4-trifluoro-1-(furan-2-yl)-3-oxobutylidene]prop-2-enehydrazide Using HRMS and NMR". Molecules, 2022, 253, (1), 2968-2994.
Jensen P, Larsen A M, Olsen K. "Forced Degradation Studies to Evaluate Profile in Drug Substances According to ICH Guidelines". J. Nat. Prod., 2014, 1157, 8540-8570.